AGP
CYTK icon

Artia Global Partners’s Cytokinetics CYTK Stock Holding History

Artia Global Partners’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-400,500
Closed -$33.4M – 52
2023
Q4 		$33.4M Buy
+400,500
New +$14.5M 9.73% 5

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Artia Global Partners's CYTK Position: Q1 2026 in Review

Artia Global Partners opened a new position in Cytokinetics (CYTK) in Q1 2026: 16,300 shares worth $1.07M. The stake represents 0.22% of the portfolio and ranks #42 among its holdings. This is a return to the name: Artia Global Partners previously reported a position in CYTK as recently as Q1 2024.

Artia Global Partners first reported a position in CYTK in Q4 2023 and has held it in 3 quarters since. The position peaked at $6.28M in Q1 2024. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Artia Global Partners held 16,300 shares of Cytokinetics worth $1.07M as of Q1 2026.
  • Cytokinetics was a new Artia Global Partners position in Q1 2026.
  • Cytokinetics made up 0.22% of Artia Global Partners's portfolio in Q1 2026, its #42 holding.
  • Artia Global Partners first reported a position in Cytokinetics in Q4 2023 and has held it in 3 quarters since.
  • Artia Global Partners's Cytokinetics position peaked at $6.28M in Q1 2024.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Artia Global Partners's 13F filing for Q1 2026, filed 15 May 2026.